We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNACW
451
DELISTED
Prime Number Acquisition I Corp. Warrant
PNACW
$5.93K ﹤0.01%
139,541
FOXO.WS
452
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$5.85K ﹤0.01%
182,350
+171,100
+1,521% +$8.47K
ADALW
453
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$5.78K ﹤0.01%
162,900
+27,400
+20% +$1.3K
PHYT.WS
454
DELISTED
Pyrophyte Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
PHYT.WS
$5.76K ﹤0.01%
48,000
+12,500
+35% +$1.01K
LITTW
455
DELISTED
Logistics Innovation Technologies Corp. Warrant
LITTW
$5.5K ﹤0.01%
50,000
-6,995
-12% -$704
MOBVW
456
DELISTED
Mobiv Acquisition Corp Warrant
MOBVW
$5.5K ﹤0.01%
100,000
PPYAW
457
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$5.48K ﹤0.01%
137,451
+4,800
+4% +$362
GSQB.WS
458
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$5.42K ﹤0.01%
135,473
-3,951
-3% -$182
CLDI.WS
459
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$5.39K ﹤0.01%
131,578
+23,678
+22% +$1.84K
NIRWW
460
DELISTED
Near Intelligence, Inc. Warrant
NIRWW
$5.36K ﹤0.01%
50,780
-121,776
-71% -$22.4K
ARBEW icon
461
Arbe Robotics Warrant
ARBEW
$317K
$5.19K ﹤0.01%
+14,411
New +$6.12K
PFTAW
462
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$5.14K ﹤0.01%
+40,000
New +$6.16K
BNAIW
463
Brand Engagement Network Warrant
BNAIW
$2.14M
$5.1K ﹤0.01%
153,262
+29,566
+24% +$931
WTMAR
464
DELISTED
Welsbach Technology Metals Acquisition Corp. one right to receive 1/10th of a share of common stock
WTMAR
$5.09K ﹤0.01%
+29,078
New +$5.85K
PRLHW
465
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$5.07K ﹤0.01%
42,250
-175
-0.4% -$17
GLSTW
466
DELISTED
Global Star Acquisition, Inc. Warrants
GLSTW
$5K ﹤0.01%
100,000
KRE icon
467
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.61B
$5K ﹤0.01%
31,600
-23,400
-43% -$1.33M
ECDAW
468
DELISTED
ECD Automotive Design Warrant
ECDAW
$4.98K ﹤0.01%
99,600
-400
-0.4% -$28
WRAC.WS
469
DELISTED
Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50
WRAC.WS
$4.93K ﹤0.01%
109,536
+17,850
+19% +$919
GNLN icon
470
Greenlane Holdings
GNLN
$1.24M
0
SWVLW icon
471
Swvl Holdings Corp Warrant
SWVLW
$4.77K ﹤0.01%
229,370
-10,806
-4% -$254
PUCKW
472
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$4.7K ﹤0.01%
99,841
+9,200
+10% +$457
AWINW
473
DELISTED
AERWINS Technologies Inc Warrant
AWINW
$4.63K ﹤0.01%
74,050
-320,638
-81% -$29.6K
GFGDW
474
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$4.47K ﹤0.01%
+46,828
New +$3.55K
FRXB.WS
475
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$4.47K ﹤0.01%
22,500
-923
-4% -$171

Similar funds

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.